Want to see TSE:ENW full AI Analyst Report?
Top Page
Enwave Corp
(ENW)
Select Model
Select Model
Rating:50Neutral
Price Target:
C$0.24
▼(-12.96% Downside)
Action:Reiterated
Date:10/21/26
The score is held down primarily by weak financial performance—persistent losses and especially deteriorating operating/free cash flow—despite a comparatively healthier balance sheet. Technicals are modestly supportive in the short term but not confirmed by longer-term trend indicators. The earnings call improves the outlook with better YoY operating momentum and credible cost/royalty targets, but inventory buildup, order timing delays, and tight borrowing headroom keep risk elevated. Valuation remains challenging due to negative earnings.
Positive Factors
Installed Base and Royalty Potential
A growing installed base with unused capacity supports additional royalty revenue without proportional infrastructure investment. The 36 active licensees and 16 entities in development provide a durable commercial foundation, while spare capacity creates room for future adoption and recurring cash generation.
Negative Factors
Persistent Operating Losses
Continued negative EBIT and net income show that the business has not yet converted its revenue base into sustainable profitability. The deterioration in TTM results increases dependence on future royalty growth, equipment sales, and cost reductions, making earnings improvement an important execution requirement.
Read all positive and negative factors
Positive Factors
Negative Factors
Installed Base and Royalty Potential
A growing installed base with unused capacity supports additional royalty revenue without proportional infrastructure investment. The 36 active licensees and 16 entities in development provide a durable commercial foundation, while spare capacity creates room for future adoption and recurring cash generation.
Read all positive factors
Enwave Corp (ENW) vs. iShares MSCI Canada ETF (EWC)
Market Cap
C$22.56M
Dividend YieldN/A
Average Volume (3M)33.56K
Price to Earnings (P/E)―
Beta (1Y)0.03
Revenue Growth9.31%
EPS Growth-124.29%
CountryCA
Employees27
SectorGeneral
Sector StrengthN/A
IndustryIndustrial - Machinery
Share Statistics
EPS (TTM)-0.02
Shares Outstanding118,716,720
10 Day Avg. Volume19,351
30 Day Avg. Volume33,557
Financial Highlights & Ratios
PEG Ratio1.21
Price to Book (P/B)3.45
Price to Sales (P/S)2.99
P/FCF Ratio-63.02
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusModerate Buy
Number of Analyst Covering1
EPS Forecast (FY)0.01
Revenue Forecast (FY)C$24.00M
Enwave Corp Business Overview & Revenue Model
Company Description
EnWave Corporation designs, constructs, markets, and sells vacuum-microwave dehydration machinery for the food, cannabis, and biomaterial industries in Canada, the United States, and internationally. The company licenses radiant energy vacuum (REV...
How the Company Makes Money
Enwave makes money by selling district energy services to customers connected to its thermal networks and plants. Its core revenue model is based on long-term, contracted or recurring service relationships in which Enwave produces thermal energy (...
Enwave Corp Earnings Call Summary
Earnings Call Date:Aug 21, 2026
(Q3-2026)
| % Change Since: |
Next Earnings Date:Dec 10, 2026
Earnings Call Sentiment Positive
Overall the call conveyed a constructive and improving operational and financial picture: revenue and royalties grew materially year-over-year, gross margins and adjusted EBITDA showed meaningful improvement, the company secured a repeat large-scale machine order and multiple new licenses/evaluations (including with blue-chip partners), and management has a clear plan to reduce operating expenses. Offsetting these positives are timing delays for several large machine orders, a significant inventory buildup that ties up cash, continued reliance on a small number of high-impact deals for near-term revenue, and a still-negative adjusted EBITDA. Given the balance of strong momentum in royalties, pipeline expansion and repeat orders against manageable but notable execution and timing risks, the overall tone is cautiously optimistic.Positive Updates
Revenue Growth
Q3 revenue of $3.33 million, up 21% year-over-year (increase of $569k vs Q3 FY25), driven primarily by the sale of a fully fabricated large-scale REV machine to Procescir and higher base royalties.
Negative Updates
Timing and Delays in Large Equipment Orders
Several anticipated large-scale machine sales were delayed from earlier quarters; one large opportunity was lost (alternative protein customer chose a cheaper air-drying solution) and three others remain active but pushed into FY27 — creating uneven revenue recognition and near-term uncertainty.
Read all updates
Q3-2026 Updates
Positive
Negative
Revenue Growth
Q3 revenue of $3.33 million, up 21% year-over-year (increase of $569k vs Q3 FY25), driven primarily by the sale of a fully fabricated large-scale REV machine to Procescir and higher base royalties.
Read all positive updates
Company Guidance
Management guided that royalties should "push toward" CA$3.0 million in fiscal 2027 and said they plan to cut operating expenses by more than CA$1.0 million by fiscal 2028 (targeting base expenses of about CA$3.5M), with the goal that royalties exceed base cash operating costs by 2028; Q3 results highlighted CA$3.33M revenue (+21% YoY), 25% gross margin (+6 pts YoY; YTD gross margin 30%), base royalties of CA$536k (+24% YoY) (reduced by a one‑time ~CA$60k adjustment, with normalized base royalties ~CA$600k), adjusted EBITDA loss of CA$93k vs. CA$575k loss prior year (improvement CA$480k), SG&A (incl. R&D) CA$1.2M (‑15% YoY), cash CA$2.5M, net working capital CA$7.1M, inventory CA$3.0M vs CA$1.4M year‑end (+118%) driven by a ~90%‑complete 100 kW machine and 10 kW units, a CA$2.3M credit facility (CA$1.9M drawn, CA$360k undrawn), and a strengthened pipeline/engagement metrics (772 new qualified leads in Q3, ~120 meetings, ~1,200 nurturing emails; 36 active licensees, 16 in development, ~25–30% spare installed capacity), including a repeat 120 kW order from Procescir and anticipated blue‑chip product launches in fiscal/calendar 2027.Enwave Corp Financial Statement Overview
Summary
Income Statement
34
Negative
Balance Sheet
62
Positive
Cash Flow
28
Negative
| Breakdown | TTM | Sep 2025 | Sep 2024 | Sep 2023 | Sep 2022 | Sep 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 12.29M | 13.83M | 8.18M | 11.36M | 23.70M | 26.48M |
| Gross Profit | 4.37M | 4.64M | 2.66M | 4.24M | 6.29M | 7.17M |
| EBITDA | -173.00K | 28.00K | -1.05M | -334.00K | -1.43M | -1.64M |
| Net Income | -1.79M | -418.00K | -2.40M | -6.51M | -6.93M | -4.13M |
Balance Sheet | ||||||
| Total Assets | 16.04M | 18.55M | 13.15M | 16.03M | 25.85M | 30.64M |
| Cash, Cash Equivalents and Short-Term Investments | 2.53M | 6.40M | 4.76M | 4.17M | 6.20M | 11.79M |
| Total Debt | 4.49M | 3.10M | 1.57M | 1.38M | 2.43M | 1.78M |
| Total Liabilities | 6.53M | 6.55M | 3.73M | 4.47M | 8.22M | 7.65M |
| Stockholders Equity | 9.51M | 11.99M | 9.42M | 11.56M | 17.63M | 22.99M |
Cash Flow | ||||||
| Free Cash Flow | -5.80M | -657.00K | 1.17M | -2.56M | -4.96M | -24.00K |
| Operating Cash Flow | -5.60M | -546.00K | 1.39M | -2.51M | -2.26M | 2.04M |
| Investing Cash Flow | -220.00K | -111.00K | -116.00K | 1.36M | -2.52M | -1.82M |
| Financing Cash Flow | 3.69M | 2.22M | -692.00K | -900.00K | -939.00K | -2.93M |
Enwave Corp Technical Analysis
Negative
0.27
Price Trends
0.22
Negative
0.23
Negative
0.26
Negative
Market Momentum
>-0.01
Positive
40.68
Neutral
16.36
Positive
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For TSE:ENW, the sentiment is Negative. The current price of 0.27 is above the 20-day moving average (MA) of 0.21, above the 50-day MA of 0.22, and above the 200-day MA of 0.26, indicating a bearish trend. The MACD of >-0.01 indicates Positive momentum. The RSI at 40.68 is Neutral, neither overbought nor oversold. The STOCH value of 16.36 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for TSE:ENW.
Enwave Corp Peers Comparison
UnderperformOutperform
Sector (55)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
61 Neutral | C$27.42M | 8.73 | 6.20% | 3.88% | 7.21% | ― | |
56 Neutral | C$45.27M | -4.07 | 112.32% | ― | 11.62% | 16.81% | |
55 Neutral | $6.65B | 3.83 | -15.92% | 6.20% | 10.91% | 7.18% | |
50 Neutral | C$22.56M | -11.46 | -16.94% | ― | 9.31% | -124.29% | |
47 Neutral | C$12.59M | -14.37 | -5.66% | ― | -8.43% | -233.47% | |
43 Neutral | C$49.81M | -5.05 | 718.52% | ― | -57.68% | 24.90% | |
42 Neutral | C$27.18M | -2.88 | -138.91% | ― | 374.59% | 74.40% |
* General Sector Average
TSE:ENW
Enwave Corp
0.19
-0.16
-45.71%
TSE:DYA
dynaCERT
0.10
-0.04
-27.41%
TSE:PYR
PyroGenesis Canada
0.20
-0.03
-13.04%
TSE:REKO
Reko International
5.00
1.27
34.05%
TSE:TLA
Titan Logix
0.47
-0.07
-12.96%
TSE:NXH
Next Hydrogen Solutions Inc
0.40
-0.14
-25.93%
Enwave Corp Corporate Events
Business Operations and StrategyProduct-Related Announcements
EnWave Secures Royalty-Bearing License With Ashland, Sells Two REV Units
Positive
Oct 9, 2026
EnWave Corporation has signed a royalty-bearing commercial license with Ashland Dehydrated Foods LLC and sold two 10kW Radiant Energy Vacuum machines to the Oregon-based contract manufacturer. Ashland will deploy the REV units to expand its dehydr...
Business Operations and StrategyProduct-Related Announcements
EnWave’s REV Technology Powers Loovies’ Launch of Ultra-Healthy Snack Styx
Positive
Aug 25, 2026
EnWave announced that Loovies LLC, a previously unnamed Mexican royalty partner, is launching Loovies Styx, a new healthy snack produced using EnWave’s Radiant Energy Vacuum technology. Loovies, which bought a 10kW REV machine and is buildin...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.